FKBP5 and neoplasm: A previous in vivo study has shown the specificity and efficacy of FKBP51 siRNA in reducing levels of FKBP51 persistently in tumour xenografts.8, 36 The siRNA efficacy and specificity is shown in Supplementary Figure S6.